William B. Horne
2013 - Targeted Medical Pharma
In 2013, William B. Horne earned a total compensation of $142.1K as Chief Financial Officer at Targeted Medical Pharma.
Compensation breakdown
| Option Awards | $72,558 |
|---|---|
| Salary | $69,519 |
| Total | $142,077 |
Horne received $72.6K in option awards, accounting for 51% of the total pay in 2013.
Horne also received $69.5K in salary.
Rankings
In 2013, William B. Horne's compensation ranked 11,931st out of 12,286 executives tracked by ExecPay. In other words, Horne earned more than 2.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,931 out of 12,286 | 3rd |
Division Manufacturing | 4,469 out of 4,612 | 3rd |
Major group Chemicals And Allied Products | 1,414 out of 1,462 | 3rd |
Industry group Drugs | 1,121 out of 1,156 | 3rd |
Industry Pharmaceutical Preparations | 864 out of 890 | 3rd |
Source: SEC filing on April 30, 2014.
Horne's colleagues
We found five more compensation records of executives who worked with William B. Horne at Targeted Medical Pharma in 2013.
2013
David Silver
Targeted Medical Pharma
Chief Operating Officer
2013
William Shell
Targeted Medical Pharma
Chief Executive Officer
2013
Kim Giffoni
Targeted Medical Pharma
Executive Vice President of Foreign Sales and Investor Relations
2013
Amir Blachman
Targeted Medical Pharma
VP of Strategy and Operations and Chief Compliance and Ethics Officer
2013
Douglas Gintz
Targeted Medical Pharma